Skip to main content

Table 1 Population characteristics according to the presence of undiagnosed chronic obstructive pulmonary disease (COPD)

From: Methylation of SERPINA1 gene promoter may predict chronic obstructive pulmonary disease in patients affected by acute coronary syndrome

General characteristics, mean ± SD

COPD−

(n = 85)

COPD+

(n = 30)

p value

Age, years

63 ± 9

70 ± 8

0.001

BMI, Kg/m2

27.7 ± 4.2

27 ± 3.6

0.420

Male, n° (%)

73 (86)

23 (77)

0.243

CV risk factors and comorbidities, n° (%)

Diabetes

19 (22)

9 (30)

0.401

Hypertension

58 (68)

18 (60)

0.413

Family history of CAD

23 (27)

8 (27)

0.967

Dyslipidemia

47 (55)

13 (43)

0.260

Pre-MI

10 (12)

8 (27)

0.053

Pre-PCI

17 (20)

3 (10)

0.214

Pre-CABG

3 (4)

2 (7)

0.469

AF

8 (9)

3 (10)

0.925

PAD

4 (5)

2 (7)

0.678

COPD parameters

   

RHSQ > 19, n° (%)

25 (29)

17 (57)

0.008

FEV1, L, mean ± SD

2.9 ± 0.7

2.0 ± 0.5

 < 0.001

Smoker, n° (%)

39 (46)

15 (50)

0.698

Former smokers, n° (%)

46 (54)

15 (50)

0.698

Pack years, mean ± SD

34 ± 23

45 ± 38

0.049

Clinical presentation and coronary vessel disease, n° (%)

STEMI

38 (45)

15 (50)

0.617

NSTEMI

27 (32)

10 (33)

0.874

Unstable angina

20 (24)

5 (17)

0.433

Descending artery

67 (79)

18 (60)

0.051

Circumflex artery

44 (52)

12 (40)

0.268

Right coronary artery

61 (72)

18 (60)

0.232

Left main

12 (14)

5 (17)

0.551

Therapy, n° (%)

   

Aspirin

84 (99)

30(100)

0.553

P2Y12 inhibitor

85 (100)

30(100)

0.999

Beta-blockers

72 (85)

28(93)

0.228

ACE inhibitors

77 (91)

28(93)

0.646

Statins

83 (98)

28(93)

0.268

Laboratory data, mean ± SD

   

Troponin T, ng/dl

1.99 ± 2.7

2.3 ± 4.3

0.643

CK-MB peak

78 ± 119

90 ± 141

0.676

WBC admission, u/μl

9.4 ± 3.05

9.5 ± 2.94

0.998

WBC discharge, u/μl

8.48 ± 2.21

7.91 ± 1.88

0.209

Lymphocytes, u/μl, admission

2.14 ± 0.99

1.95 ± 0.96

0.365

Lymphocytes, u/μl, discharge

1.85 ± 0.57

1.74 ± 0.73

0.352

Neutrophils, u/μl, admission

6.11 ± 2.66

5.95 ± 2.06

0.763

Neutrophils, u/μl, discharge

5.56 ± 1.84

4.91 ± 1.36

0.081

NLR, admission

3.47 ± 2.17

3.78 ± 2.51

0.516

NLR, discharge

3.24 ± 1.44

3.39 ± 1.88

0.639

  1. COPD+: ACS patients, with chronic obstructive pulmonary disease (COPD). COPD−: ACS patients without COPD. WBC: white blood cell, SD: standard deviation, ACE: angiotensin-converting enzyme, STEMI: ST-elevation myocardial infarction, NSTEMI: non-ST-elevation myocardial infarction, MI: myocardial infarction, PCI: percutaneous coronary intervention, CABG: coronary artery bypass graft, AF: atrial fibrillation, PAD: peripheral artery disease, COPD: chronic obstructive pulmonary disease, FEV1: forced expiratory volume at first second, FVC: forced vital capacity, RHSQ: respiratory health screening questionnaire, HDL: high-density lipoprotein, CAD: coronary artery disease, CV: cardiovascular, BMI: body mass index, BSA: body surface area. u/μl: cell/μl, NLR: neutrophil/lymphocyte ratio